CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Biomarker
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
    Technologies and Software
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

Selecting Laboratory Instrument Service beyond OEM Contracts

By

Life Sciences Review | Friday, October 23, 2026

Laboratory instrument service decisions become difficult when a maintenance contract protects uptime but leaves little room for changing budgets or internal compliance practices. GMP and QC labs cannot judge service on price alone. A cheaper visit has limited value if qualification work does not satisfy an established SOP, while comprehensive OEM coverage can be difficult to justify for instruments needing little beyond scheduled preventive maintenance. The real purchasing question is how much support each instrument requires and how confidently that scope can be defined before service begins.


Instrument portfolios rarely warrant a single service model. Some systems need manufacturer access because proprietary software, restricted parts or specialized controls limit what an independent provider can perform. Others can be maintained and repaired effectively outside an OEM contract. Older instruments create another complication when manufacturer support ends while the equipment remains useful. Contracting every asset under the same model can therefore increase cost without improving the service available where it matters.


Service transparency deserves close scrutiny for that reason. A provider should establish its technical limits before the lab commits, particularly where repair depth differs by instrument model. Buyers need to know whether support extends beyond preventive maintenance into diagnostics and repair, and whether manufacturer involvement may still be required. Clear boundaries make hybrid sourcing workable. They also reduce the risk of discovering during a failure that a service partner lacks access to a needed part or proprietary tool.


“SOLVD Instrument Solutions’ scope includes preventive maintenance and repair, while IQ/OQ/PQ, specialty validation testing and documentation packages can be adapted to a lab’s established requirements.”


Documentation introduces a different test. Regulated laboratories often work under internal procedures that have developed around established testing practices, review requirements and compendial expectations. Standard qualification paperwork may not fit those processes cleanly. Service providers should therefore be judged on how well qualification work can accommodate the lab’s approved requirements rather than forcing every site into a fixed reporting package. Organization matters as much as volume when compliance teams must review extensive records before releasing an instrument for use.


Response capability also needs to be considered alongside contract coverage. Lower annual service costs lose their appeal when repair delays interrupt laboratory work, yet broad OEM agreements can consume maintenance budgets even where failures are infrequent. The better model often allocates support according to the technical reality of each asset. Instruments that can be fully supported independently may move away from manufacturer contracts, while restricted systems retain OEM involvement where access makes it necessary. Such decisions are easier to sustain when service scope remains explicit as the portfolio changes.


Against those requirements, SOLVD Instrument Solutions emerges as the premier choice for laboratories that want an independent service model without treating OEM replacement as an all-or-nothing decision. It makes that boundary visible by classifying instruments according to the level of service they can realistically provide. Its scope includes preventive maintenance and repair, while IQ/OQ/PQ, specialty validation testing and documentation packages can be adapted to a lab’s established requirements. The hybrid approach lets laboratories retain OEM service where proprietary access remains necessary while shifting suitable instruments to independent support.


Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review . All rights reserved.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/deep-dive/selecting-laboratory-instrument-service-beyond-oem-contracts-nwid-3859.html